XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income $ 42,592 $ 63,696 $ 21,654
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation, amortization and accretion expense 77,158 80,625 77,852
Amortization of deferred financing costs 3,287 2,788 1,862
Credit loss expense 40 232 253
Deferred income tax expense (benefit) 1,572 (1,753) (3,761)
Equity-based employee and director compensation expense 3,031 2,294 1,311
Gain on dispositions and lease terminations, net (4,737) (1,143) (2,037)
Changes in operating assets and liabilities, net of acquisitions (5,860) 14,578 (1,666)
Net cash provided by operating activities 117,083 161,317 95,468
Cash flows from investing activities:      
Principal payments received on notes receivable 213 203 793
Proceeds from sale of assets 6,234 13,344 15,359
Capital expenditures (34,628) (30,351) (41,859)
Cash paid in connection with acquisitions, net of cash acquired   (29,594) (272,983)
Net cash used in investing activities (28,181) (46,398) (298,690)
Cash flows from financing activities:      
Borrowings under revolving credit facilities 240,900 114,100 194,895
Repayments on revolving credit facilities (91,037) (138,538) (77,500)
Borrowings under the Term Loan Facility   1,120 182,460
Repayments on the Term Loan Facility (158,980) (24,600)  
Net proceeds from issuance of preferred membership interests   24,430  
Payments of finance lease obligations (2,890) (2,724) (2,604)
Payments of deferred financing costs (7,106) (474) (7,201)
Distributions paid on distribution equivalent rights (241) (202) (141)
Income tax distributions paid on preferred membership interests (900)    
Distributions paid on common units (79,712) (79,625) (79,552)
Net cash (used in) provided by financing activities (99,966) (106,513) 210,357
Net (decrease) increase in cash and cash equivalents (11,064) 8,406 7,135
Cash and cash equivalents at beginning of period 16,054 7,648 513
Cash and cash equivalents at end of period $ 4,990 $ 16,054 $ 7,648